Protein disulphide isomerase (PDI) is a key enzyme responsible for the formation of native disulphide bonds in proteins that enter the secretory pathway of eukaryotic cells. PDI is a multifunctional protein able to catalyse the oxidation and isomerisation of disulphide bonds, as well as to bind to unfolded proteins and act as a molecular chaperone.^[@cit1]^ The isomerisation of incorrectly paired cysteine residues is often a rate-limiting step on the folding pathway of disulphide bond-containing proteins both *in vitro* and *in vivo*.^[@cit2]^ The ability of PDI to combine redox and molecular chaperone-like activities allows it to bind to partly structured folding intermediates and to catalyse simultaneously protein folding and associated native disulphide bond formation.^[@cit3]^ PDI is the archetype of a large family of ER-resident PDI-like proteins.^[@cit2]^

PDI contains four thioredoxin-like domains, two of which -- like thioredoxin itself -- have redox-active catalytic sites (**a** and **a**′) and two of which do not (**b** and **b**′). The domain order is **a-b-b**′-**x-a**′-**c**, where **x** is a 19 residue linker between the **b**′ and **a**′ domains^[@cit4],[@cit5]^ and **c** is a C-terminal acidic tail containing the KDEL ER-retention signal. The **a** and **a**′ domains are responsible for the redox activity of PDI while the **b**′ domain has been shown to be essential for ligand binding.^[@cit6]^ The **b**′ domain binds both small and large peptide ligands, although large ligands also require the **a** and **a**′ domains to contribute to the overall binding interaction.^[@cit6],[@cit7]^ The **b**′ domain has been shown to contribute to the substrate specificity of PDI^[@cit4],[@cit8]^ and is required for disulphide isomerisation reactions in protein substrates.^[@cit9]^

The nature of substrate binding involving the **b**′ domain continues to be a subject of interest and any information regarding the role of **b**′ and **x** is extremely useful. Recent studies have highlighted the **b**′ domain of human PDI (hPDI) to be structurally connected and influenced by **x**, the linker that connects the **b**′ and **a**′ domains. The **b**′**x** construct has been shown to be receptive to ligand binding^[@cit4]^ and **x** has also been shown to moderate homodimerisation in **b**′**x** and **bb**′**x**.^[@cit10]^ These data supported the previously published crystal structure studies of a **b**′**x** mutant that confirms **b**′ contains the thioredoxin-fold with **x** occluding the ligand binding site as mapped using NMR chemical shifts.^[@cit4],[@cit11]^ As a result, it is thought that **b**′**x** exists in two conformational states with the **x-linker** 'capping' or 'uncapping' the ligand binding site and that 'uncapping' provided opportunity for homodimerisation.^[@cit4],[@cit10]^ Limited proteolysis, using wild-type and mutant proteins to promote or retard 'capping', confirmed the **x-linker** operates similarly in full-length hPDI.^[@cit12]^ Homodimerisation in hPDI is a mechanism by which the binding site is hidden from substrates, and has been proposed as a potential regulation mechanism for the protein *in vivo*.^[@cit10]^

hPDI **bb**′**x** and **bb**′ have been studied using ^1^H, ^15^N-HSQC chemical shift mapping to provide estimated dissociation constants (*K* ~d~) with peptide ligands Δ-somatostatin (AGSKNFFWKTFTSS) and mastoparan (INLKALAALAKKIL)^[@cit4],[@cit8]^ with these studies approximating the *K* ~d~ in the range of 0.1--1.0 mM. Despite these investigations, the role of the **x-linker** remains a point of conjecture because backbone resonances in the linker itself were notoriously difficult to observe and track in the ^1^H, ^15^N-HSQC ligand binding studies mentioned above due to chemical shift line broadening. Therefore, we present this concise study of **x** within **b**′**x** using ^19^F NMR to follow the displacement of the 'capped' form of the linker when a known peptide ligand is titrated against constant protein concentration. Switching to ^19^F NMR provides an optimum detection window of the **x-linker** to observe both ligand binding and displacement of the linker from the binding site. This is facilitated by the fact that hPDI **b**′**x** contains only a single tryptophan residue that resides at position 347 within the **x-linker** and positioned directly above the reported ligand binding site as shown in [Fig. 1](#fig1){ref-type="fig"}. In addition, we also describe the rationale behind our choice of indole fluorination that provides optimal expression.

![Crystal structure of hPDI **b**′**x** I272A with the 'capped' **x-linker** shown in magenta and the ligand-binding site in yellow. Trp 347 is shown in stick form. The sequence and secondary structure of **b**′**x** is shown in ESI Fig. 1.[†](#fn1){ref-type="fn"}](c4ob00699b-f1){#fig1}

All NMR datasets were acquired at 298 K using a Bruker Avance III 14.1 T (600 MHz ^1^H) NMR spectrometer equipped with a 5 mm QCI-F cryoprobe. Data were processed using Bruker Topspin 3.1 software and referenced using the position of the ^1^H~2~O, relative gyromagnetic ratios (for ^15^N) or using trifluoroacetic acid (for ^19^F). Bacterial expression and purification of all proteins were identical to that reported previously for hPDI **b**′**x** ^[@cit4],[@cit10]^ with additional steps only to permit fluorination in accordance with the recently published protocol by Crowley and co-workers.^[@cit13]^ For convenience, the entire growth protocol and purification can be found in the ESI.[†](#fn1){ref-type="fn"} The method utilises a standard bacteria minimal growth media with 60 mg L^--1^ of indole, 5-fluoroindole or 6-fluoroindole added 15 minutes prior to induction with IPTG (isopropyl β-[d]{.smallcaps}-1-thiogalactopyranoside). All indoles were added to the growth media from a 200× dimethylsulfoxide (DMSO) stock solutions. An SDS-PAGE gel illustrating the effect of each indole on expression of hPDI **b**′**x** is shown in [Fig. 2](#fig2){ref-type="fig"}.

![15% SDS-PAGE of hPDI **b**′**x** showing samples taken pre- and post-induction in minimal media without indole, with indole, with 5-fluoroindole (5-F) and with 6-fluoroindole (6-F). Lane 1 shows Precision-Plus protein standard markers labelled with molecular weight (kDa) and the black arrow highlights the position of **b**′**x**.](c4ob00699b-f2){#fig2}

The inclusion of indole using DMSO as a stock carrier liquid did not hinder induction of the protein and the addition of 5-fluoroindole did also not alter the protein yield. From a minimal growth medium both indole and 5-fluoroindole provided yields of 6--8 mg L^--1^ of purified protein. However, [Fig. 2](#fig2){ref-type="fig"} highlights the effect of using 6-fluoroindole where the yield of recombinant **b**′**x** was found to be consistently lower than for indole and 5-fluoroindole with an estimated yield of *ca.* 0.5 mg L^--1^.

Differences in fluoroindole overexpression are likely be related to the positioning of the fluorine in the indole ring and the SDS-PAGE gel in [Fig. 2](#fig2){ref-type="fig"} highlights the importance of utilising fluorination that supports correct folding of a stable protein. This hypothesis was further corroborated using mass spectrometry (Bruker MicroTOF-Q) where 5-F-Trp incorporation was found to be \>80% but 6-F-Trp incorporation was *ca.* 55% (see ESI Fig. 2[†](#fn1){ref-type="fn"}) confirming that 6-F-Trp incorporation was less successful. In an attempt to understand the effect of fluorination, [Fig. 3](#fig3){ref-type="fig"} uses the 'capped' **b**′**x** I272A structure with *in silico* modified tryptophans to highlight the structural effects of 5-fluoro- (5-F-Trp: [Fig. 3a](#fig3){ref-type="fig"}) or 6-fluorotryptophan (6-F-Trp: [Fig. 3b](#fig3){ref-type="fig"}) labelling of **b**′**x**.

![Structure of hPDI **b**′**x**′ I272A (; 3bj5.pdb) showing the **x-linker** tryptophan modified *in silico* with fluorine inserted into the indole ring as a green van der Waals sphere to represent 5-F labelling (a) and 6-F labelling (b).](c4ob00699b-f3){#fig3}

Close inspection of these structures suggests that when fluorine is present as 6-F-Trp, the fluorine is packed against residues F223, I284, F287 and F288 (see ESI Fig. 3a[†](#fn1){ref-type="fn"}). These four residues were emphasised as providing key interactions between **b**′ and the **x-linker** in the crystal structure.^[@cit11]^ In contrast, inspection of the structure where fluorine is present using 5-F-Trp confirms that this structure experiences fewer critical interactions because the fluorine atom resides in a pocket above the ligand-binding site ([Fig. 3a](#fig3){ref-type="fig"} and ESI Fig. 3b[†](#fn1){ref-type="fn"}). The structural stability difference expected for 5-F-Trp *versus* 6-F-Trp is a likely explanation for the difference in expression yields when using 5-fluoro- and 6-fluoroindole. It could be suggested that 6-fluoroindole may have compromised cell metabolism resulting in the loss of production. However, observed growth rates were similar regardless of indole utilised and close inspection of post-expression gel bands in [Fig. 2](#fig2){ref-type="fig"} between 20--100 kDa supports comparable background protein levels across all samples. This observation would support that 6-fluoroindole does not adversely affect tryptophan synthase because many of these background proteins must also require tryptophan. In addition, we can confirm from other studies that 6-fluoroindole can be used to successfully produce other proteins with 6-F-Trp (unpublished results). However, these data do highlight the need to carefully consider the choice of fluorination sites when producing labelled proteins. The structural integrity of wild-type **b**′**x** expressed in the presence and absence of 5-F-Trp was assessed using ^1^H, ^15^N-HSQC data obtained from samples grown in minimal media containing a single nitrogen source of 0.6 mg L^--1^ U-^15^N ammonium sulphate. ^1^H, ^15^N-HSQC **b**′**x** and **5-F-Trp-b**′**x** spectra are shown in [Fig. 4](#fig4){ref-type="fig"}. The spectra overlay extremely well and suggest both samples have the same fold and structural arrangement, which is confirmed *via* a minimal chemical shift map analysis of the data (ESI Fig. 4[†](#fn1){ref-type="fn"}). Furthermore, these data are also comparable to previously published ^1^H, ^15^N-HSQC spectra of wild-type and **x-linker** 'capping' mutants of **b**′**x**.^[@cit4],[@cit11]^

![^1^H, ^15^N-HSQC spectra of hPDI **b**′**x** (a) and **5-F-Trp-b**′**x** (b) from 0.25 mM protein samples. Data were acquired for each spectrum as 2048 × 256 points over 45 minutes.](c4ob00699b-f4){#fig4}

The degree of fluorination was estimated by comparing the relative ratios of the indole NH peaks in the ^1^H, ^15^N-HSQC spectra of **b**′**x** and **5-F-Trp-b**′**x** and was found to vary between 80--90% depending on the preparation. This is in good agreement with the mass spectrometry data shown in ESI Fig. 2.[†](#fn1){ref-type="fn"} ^19^F NMR spectra of 0.3 mM hPDI **5-F-Trp-b**′**x** were obtained with increasing Δ-somatostatin peptide concentration and are shown in [Fig. 5](#fig5){ref-type="fig"}. Each 1D ^19^F NMR experiment was acquired over 1024 scans using a relaxation delay of 2 s and an acquisition time of 0.321 s. The data obtained in [Fig. 5](#fig5){ref-type="fig"} demonstrates the utility of the QCI-F cryoprobe and the ability to create a dataset within half the time required to acquire a ^1^H, ^15^N-HSQC dataset. This is especially important because **b**′**x** is prone to dimerise over time and the monomeric state in the predominantly 'capped' **x** conformation is required for this measurement. It is for this reason that a spectrum of a 48-hour 'aged' **b**′**x** sample is also shown in [Fig. 5](#fig5){ref-type="fig"} where both 'capped' and 'uncapped' forms can be distinguished by ^19^F NMR. Using a fresh, purified sample enabled the titration of Δ-somatostatin to be monitored through a single ^19^F resonance that reports on the **x-linker** status as the peak tracks from the 'capped' toward the 'uncapped' state. It is interesting to note the reduction in ^19^F resonance line width as ligand is added; this supports the displacement of the **x-linker** in **b**′**x** as ligand binds to the protein. Once the linker is displaced, it will display increased mobility compared to the bulk protein, which manifests as an increase in the ^19^F T~2~ relaxation time and subsequent reduction in line width. This reduction in linewidth associated with **x-linker** displacement has also been observed in ^1^H, ^15^N HSQC spectra.^[@cit4],[@cit11]^ The change in ^19^F chemical shift with ligand concentration from [Fig. 5](#fig5){ref-type="fig"} can be plotted as shown in [Fig. 6](#fig6){ref-type="fig"} and fitted using the well-documented equation below^[@cit14],[@cit15]^ where *Δ* is the observed change in chemical shift, *Δ* ~o~ is the maximum shift and \[L\] and \[P\] are ligand and protein concentration respectively.![](c4ob00699b-t1.jpg){#ugt1}

![^19^F NMR spectra of 0.3 mM **5-F-Trp-b**′**x** with increasing concentration of Δ-somatostatin peptide (Δ-som). ^19^F NMR spectra of 48 h 'aged' **5-F-trp-b**′**x** shows ^19^F resonances reporting on 'capped' and 'uncapped' **x-linker** and 5-fluoroindole are also shown.](c4ob00699b-f5){#fig5}

![Titration saturation curve of 0.3 mM **5-F-Trp-b**′**x** when increasing the concentration of Δ-somatostatin peptide-ligand. Fitting the points to the equation provides the curve and solution for *K* ~d~ of 23 ± 4 μM.](c4ob00699b-f6){#fig6}

Solving the equation to fit the curve in [Fig. 6](#fig6){ref-type="fig"} produces a dissociation constant for hPDI **5-F-Trp-b**′**x** with Δ-somatostatin of 23 ± 4 μM. This value is marginally lower than that obtained from earlier studies that report *K* ~d~ is in the 1.0--0.1 mM range and suggests the affinity of **5-F-Trp-b**′**x** for Δ-somatostatin is higher than for the wild-type **b**′**x** protein. This likely to be due to a small but significant destabilisation of 'capped' species caused by fluorination that promotes displacement of the **x-linker** and exposure of the binding site. Fluorine substitutions in proteins and peptides have been known to stabilise and drive hydrophobic interactions and the ligand-binding process across many PDIs including hPDI **b**′**x** is considered as hydrophobically driven.

If fluorine mediated hydrophobicity increased the strength of binding of the **x-linker** region to **b**′ then one might expect 'uncapping' to be more unfavourable with the consequence that ligand affinity is reduced. This does not appear to be the case.

A third explanation could be that the ligand experiences favourable hydrophobic interactions with the 'uncapped' **x-linker**; this would manifest as increased affinity and a lower *K* ~d~. These observations suggest the smaller *K* ~d~ is driven by destabilisation of the 'capped' state and/or the 'uncapped' state experiences a hydrophobically driven binding event that is stabilised by fluorination. The latter hypothesis proposes a potential role for the **x-linker** in ligand binding and such a process has been suggested from analysis of recent crystal structures of yeast^[@cit16]^ and hPDI^[@cit17]^ as well as *in silico* modelling and SAXS analysis of PDI from *Humicola insolens.* ^[@cit18],[@cit19]^

Conclusions
===========

^19^F labelling using 5-fluoroindole to produce 5-fluorotryptophan for protein NMR spectroscopy is straightforward and successful. In addition, 5-fluoro-[l]{.smallcaps}-tryptophan is approximately 50-times more expensive than 5-fluoroindole per gram, thus making fluoroindole-based labelling economical. However, our experience draws attention to the care required to find the optimum fluoroindole for the system to be studied. hPDI **b**′**x** was best served using 5-fluoroindole but it is worth noting that 4-fluoro-, 5-fluoro- and 6-fluoroindoles are all available from general chemical suppliers. As a result, we recommend small-scale expression tests with different fluoroindoles to discover the optimum labelling strategy. Our results also suggest that interrogation of a known structure can help identify the optimum fluoroindole through analysis of close-quarter atomic interactions.

Ultimately, ^19^F NMR has provided a useful shift in the NMR timescales of detection that was a challenge regarding **x-linker** observation using ^1^H, ^15^N HSQCs. Fluorine NMR enables direct observation of the tryptophan side chain in **b**′**x** and the ^19^F chemical shift change can be used to study ligand binding and for identification of the 'capped' and 'uncapped' conformations of the protein. ^19^F NMR has also confirmed that the **x-linker** is displaced upon binding as the 5-F-Trp chemical shift tracks from the 'capped' to 'uncapped' state.

The data provides an excellent fit and a *K* ~d~ of 23 μM for Δ-somatostatin binding to **5-F-b**′**x** and this value is marginally lower than 0.1--1 mM reported for the wild-type protein. We suggest this was most likely due to destabilisation of 'capped' **5-F-b**′**x**, stabilisation of protein--peptide complex or a combination of both factors. Ultimately, this approach can be expanded further to study multiple PDI domain constructs and other PDI family members to monitor structure-function of this isomerase and folding chaperone.
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